Liver cancer patients get immunotherapy before surgery in new trial
NCT ID NCT05908786
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested giving immunotherapy drugs before surgery to people with liver cancer that could be removed. The goal was to see if these drug combinations could shrink the tumor or eliminate it before the operation. 62 participants took part in this early-phase trial, which has now been completed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, HEPATOCELLULAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Assistance Publique-Hopitaux de Paris
Villejuif, 94800, France
-
Auckland District Health Board (ADHB)
Auckland, 1023, New Zealand
-
Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus
Detroit, Michigan, 48201-2013, United States
-
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, 463-712, South Korea
-
Centre Eugene Marquis (CEM)
Rennes, 35042, France
-
Centre Georges Francois Leclerc (CGFL)
Dijon, 21079, France
-
Chang Gung Medical Foundation, Kaohsiung Chang Gung Memorial Hospital
Tainan, 83301, Taiwan
-
Clínica Universidad de Navarra
Pamplona, Navarre, 31620, Spain
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Department of Internal Medicine III AKH and Medical University of Vienna
Vienna, 1180, Austria
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Gustave Roussy
Villejuif, 94800, France
-
Hospital Clinic de Barcelona (Hospital Clinic i Provincial)
Barcelona, 8036, Spain
-
Hospital Universitario Fundacion Jimenez Diaz.
Madrid, 28040, Spain
-
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, 39008, Spain
-
Imperial College London - Imperial Centre for Translational and Experimental Medicine (ICTEM)
London, United Kingdom
-
Klinikum Klagenfurt am Wörthersee
Klagenfurt, 9020, Austria
-
National Cheng Kung University Hospital
Tainan, 70457, Taiwan
-
National Taiwan University Hospital (NTUH) - Cancer Research Center
Zhongzheng Dist., 10051, Taiwan
-
Severance Hospital, Yonsei University Health System
Seoul, 003-722, South Korea
-
Taichung Veterans General Hospital
Taichung, 40705, Taiwan
-
Taipei Veterans General Hospital
Taipei, 112, Taiwan
-
UT Southwestern Medical Center
Dallas, Texas, 75390-8813, United States
-
Universitaets Klinikum Frankfurt - Zentrum der Inneren Medizin
Frankfurt, 60596, Germany
-
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz
Mainz, 55131, Germany
-
University Essen
Essen, 45147, Germany
-
University of California Los Angeles (UCLA) - Cancer Care - Santa Monica
Santa Monica, California, 90404-2023, United States
-
University of Southern California (USC)
Los Angeles, California, 90033, United States
-
Wiener Gesundheitsverbund, Klinik Favoriten
Vienna, 1100, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple belly press make liver cancer radiation more precise?
- A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure
- Virus hunts liver tumors before chemo strikes
- New combo therapy aims to stop liver cancer from coming back
- Modified virus injected into tumors shows promise for liver cancer
- New hope for kids with rare liver tumors: tailored therapy trial shows promise